2. Fund Limited Partnership Amoon serves as Executive at Ayala Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, 2. Fund Limited Partnership Amoon has executed 8 insider transactions totaling $28.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 9, 2020 involved purchasing 63,024 shares valued at $1.2M.
2. Fund Limited Partnership Amoon currently holds 975,683 shares of Ayala Pharmaceuticals, Inc. (AYLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, 2. Fund Limited Partnership Amoon has been a net buyer of AYLA stock. They have purchased $28.9M and sold $0 worth of shares.
2. Fund Limited Partnership Amoon's most recent insider trade was on Dec 9, 2020, when they purchased 63,024 shares at $19.00 per share.
Get notified when new Form 4 filings are submitted
| $19.00 |
| Discretionary |
| Dec 8, 2020 | SEER | $0 | Conversion | 912,659 | $N/A | Discretionary |
| Dec 8, 2020 | SEER | $1.9M | Purchase | 100,000 | $19.00 | Discretionary |
| Dec 8, 2020 | SEER | $0 | Conversion | 4,121,064 | $N/A | Discretionary |
| May 12, 2020 | AYLA | $0 | Conversion | 369,231 | $N/A | Discretionary |
| May 12, 2020 | AYLA | $0 | Conversion | 508,924 | $N/A | Discretionary |
| May 12, 2020 | AYLA | $12.0M | Purchase | 800,000 | $15.00 | Discretionary |